GALENICA N overview

Galenica AG / Key word(s): Strategic Company Decision Expansion of the Executive Committee and handover of the position of CFO 06.08.2024 / 07:00 CET/CEST Press release Galenica is aligning its pharmacy business to an even greater focus on customers. With Stephan Mignot, Marketing for the pharmacies will have a direct seat on the Executive Committee. In addition, the two strategic growth areas “Products & Brands” and “Home Care” are being merged into a single unit under the management of...

Galenica AG / Key word(s): Half Year Results Galenica achieves solid growth in a challenging market environment 06-Aug-2024 / 06:45 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Press release Ad hoc announcement pursuant to Art. 53 LR Galenica Group sales grew by 2.6% to CHF 1,900.0 million in the first half of 2024. Both the “Products & Care” segment and the “Logistics & IT” segment contributed to...

Galenica AG / Key word(s): Investment Galenica increases shareholding in Redcare Pharmacy to 10% 22.07.2024 / 18:11 CET/CEST Press release Today, Galenica notified the Dutch Authority for the Financial Markets (AFM) of its 10% stake in Redcare Pharmacy N.V. As part of the strategic partnership between Galenica and Redcare Pharmacy through the establishment of the joint venture Mediservice, Galenica has held a 7.9% stake in Redcare Pharmacy since May 2023. By increasing its participation,...

Galenica AG / Key word(s): Sales Result Galenica on track with sales growth 23-May-2024 / 06:45 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Press release Ad hoc announcement pursuant to Art. 53 LR The Galenica Group made a good start to the new year with sales growth of 4.8% to CHF 1,255.5 million in the first four months of 2024. All Service Units performed well and contributed to the good sales...

Galenica AG / Key word(s): Bond Galenica successfully places a bond of over CHF 100 million 16.04.2024 / 18:05 CET/CEST Press release Today, Galenica successfully placed a fixed rate bond of over CHF 100 million. The bond has a term of 7 years and an annual coupon of 1.65%. The proceeds from the transaction will be used for general corporate purposes. With this new bond, Galenica is reducing its short-term financial liabilities and securing its long-term financing. The term until 2031 ideally...

Galenica AG / Key word(s): AGMEGM 7th Annual General Meeting: Shareholders approve all proposals 10.04.2024 / 17:29 CET/CEST Press release The seventh Annual General Meeting of Galenica Ltd. was held on 10 April 2024 at the Kursaal in Bern. The shareholders approved all the proposals put forward by the Board of Directors. They also approved the proposed dividend of CHF 2.20 per share. All members of the Board of Directors were re-elected for a term of office of one year. The seventh Annual...

Galenica AG / Key word(s): Annual Results Galenica continues to grow in the 2023 financial year 12-March-2024 / 06:45 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Press release Ad hoc announcement pursuant to Art. 53 LR The Galenica Group achieved strong growth with an increase in sales of 4.4% in the 2023 financial year and generated consolidated net sales of CHF 3,746.0 million. Adjusted for the...

Galenica AG / Key word(s): Development of Sales Galenica again achieves strong sales growth 18-Jan-2024 / 06:45 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Press release Ad hoc announcement pursuant to Art. 53 LR Galenica Group sales performed well in 2023, growing by 4.4% to CHF 3,746.0 million. As expected, sales growth of 3.3% in the second half of 2023 was lower than the +5.5% recorded in the first...